Department of Medicinal Chemistry, Merck Research Laboratories, Rahway, NJ 07065, USA. ken_wildonger@merck.com
Abstract:
A series of 2-9a bridged tetrahydrofluorenone derivatives were prepared which exhibited significant binding affinity for ERbeta and were highly selective.